These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 18945420)
1. A scientific response to prevent cervical cancer in the world. Bosch FX Vaccine; 2008 Aug; 26 Suppl 12():v-vi. PubMed ID: 18945420 [No Abstract] [Full Text] [Related]
2. [Advisory report from the Health Council of the Netherlands to include human papillomavirus vaccination in the national immunisation programme for the prevention of cervical cancer]. Stekelenburg J; Schagen van Leeuwen J Ned Tijdschr Geneeskd; 2008 Jul; 152(30):1701-2; author reply 1702. PubMed ID: 18717015 [No Abstract] [Full Text] [Related]
3. A scientific response to prevent cervical cancer in the world. Bosch FX; Vaccine; 2008 Aug; 26 Suppl 10():v-vi. PubMed ID: 18847563 [No Abstract] [Full Text] [Related]
8. Human papillomavirus, cervical cancer prevention, and more. Lowy D Vaccine; 2008 Aug; 26 Suppl 10():iii-iv. PubMed ID: 18847562 [No Abstract] [Full Text] [Related]
9. [Cervix cancer prevention--achieved success must be surpassed]. Bengt A; Strander B Lakartidningen; 2006 May 17-30; 103(20):1630; author reply 1630. PubMed ID: 16800092 [No Abstract] [Full Text] [Related]
10. Cervical cancer screening in the early post vaccine era. Waxman AG Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815 [TBL] [Abstract][Full Text] [Related]
11. Cervical cancer prevention for all the world's women: new approaches offer opportunities and promise. Wright TC; Blumenthal P; Bradley J; Denny L; Esmy PO; Jayant K; Nene BM; Pollack AE; Rajkumar R; Sankaranarayanan R; Sellors JW; Shastri SS; Sherris J; Tsu V Diagn Cytopathol; 2007 Dec; 35(12):845-8. PubMed ID: 18008343 [No Abstract] [Full Text] [Related]
12. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE; Unger ER; Saraiya M J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
13. Broad-spectrum human papillomavirus vaccines: new horizons but one step at a time. Bosch FX J Natl Cancer Inst; 2009 Jun; 101(11):771-3. PubMed ID: 19470950 [No Abstract] [Full Text] [Related]
14. Prevention of cervical cancer: where immunology meets diagnostics. Meijer CJ; Heideman DA; Berkhof H; Snijders PJ Immunol Lett; 2009 Feb; 122(2):126-7. PubMed ID: 19100775 [TBL] [Abstract][Full Text] [Related]
15. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme]. de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259 [No Abstract] [Full Text] [Related]
16. Vaccination against human papillomavirus. BMJ Group Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700 [TBL] [Abstract][Full Text] [Related]
17. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications. Goldie SJ; O'Shea M; Diaz M; Kim SY Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626 [TBL] [Abstract][Full Text] [Related]
19. Public health issues related to HPV vaccination. Hershey JH; Velez LF J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306 [TBL] [Abstract][Full Text] [Related]
20. Preparing for HPV vaccination in South Africa: key challenges and opinions. Harries J; Moodley J; Barone MA; Mall S; Sinanovic E Vaccine; 2009 Jan; 27(1):38-44. PubMed ID: 18977271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]